SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3mg6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_U_TRPU81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		4 / 8 GLY J 102
HIS J  40
THR J  41
ILE J 101
 None
 0.82A 1c9sU-3mg6J:
undetectable
1c9sV-3mg6J:
undetectable		 1c9sU-3mg6J:
14.52
1c9sV-3mg6J:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EE2_B_CHDB1250_1
(ALCOHOL
DEHYDROGENASE)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 SER N 158
LEU N 159
CYH N  44
VAL N   6
ILE N 126
 None
 1.19A 1ee2B-3mg6N:
undetectable		 1ee2B-3mg6N:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_U_TRPU81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		5 / 10 GLY J 102
HIS J  40
THR J  41
ILE J 101
ALA J  78
 None
 1.20A 1gtnU-3mg6J:
undetectable
1gtnV-3mg6J:
undetectable		 1gtnU-3mg6J:
14.52
1gtnV-3mg6J:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JLB_A_NVPA999_1
(HIV-1 RT A-CHAIN)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		4 / 8 LEU J 162
VAL J 173
GLY J 172
LEU J   4
 None
 0.80A 1jlbA-3mg6J:
undetectable		 1jlbA-3mg6J:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_A_THAA1_1
(LIVER
CARBOXYLESTERASE I)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 PHE N  83
GLY N 103
VAL N 184
LEU N 178
LEU N  63
 None
 1.13A 1mx1A-3mg6N:
undetectable		 1mx1A-3mg6N:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NP1_A_HSMA303_1
(NITROPHORIN 1)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		4 / 5 GLU J 149
LEU J 155
LEU J 152
LEU J 154
 None
 0.98A 1np1A-3mg6J:
undetectable		 1np1A-3mg6J:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 GLY N  98
ALA N  97
GLY N 117
VAL N  59
ILE N  55
 None
 0.84A 2bpxB-3mg6N:
undetectable		 2bpxB-3mg6N:
21.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_2_BO221405_1
(PROTEASOME COMPONENT
PRE3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		7 / 11 THR N   1
THR N  20
ALA N  27
ARG N  45
SER N  46
ALA N  49
SER N 169
 None
 1.34A 2f162-3mg6N:
38.3		 2f162-3mg6N:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_2_BO221405_1
(PROTEASOME COMPONENT
PRE3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 11 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
SER N 168
 None
 0.55A 2f162-3mg6N:
38.3		 2f162-3mg6N:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_H_BO2H1400_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.64A 2f16H-3mg6N:
29.3
2f16I-3mg6N:
27.5		 2f16H-3mg6N:
31.05
2f16I-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F16_K_BO2K1402_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.57A 2f16K-3mg6N:
29.0
2f16L-3mg6N:
25.3		 2f16K-3mg6N:
27.18
2f16L-3mg6N:
23.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_N_BO2N1404_1
(PROTEASOME COMPONENT
PRE3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  20
ARG N  45
SER N  46
ALA N  49
SER N 169
 None
 1.39A 2f16N-3mg6N:
38.4		 2f16N-3mg6N:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_N_BO2N1404_1
(PROTEASOME COMPONENT
PRE3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 11 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
SER N 168
 None
 0.54A 2f16N-3mg6N:
38.4		 2f16N-3mg6N:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_V_BO2V1401_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.65A 2f16V-3mg6N:
29.3
2f16W-3mg6N:
27.5		 2f16V-3mg6N:
31.05
2f16W-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F16_Y_BO2Y1403_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.56A 2f16Y-3mg6N:
16.6
2f16Z-3mg6N:
25.1		 2f16Y-3mg6N:
27.18
2f16Z-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R5P_B_MK1B902_2
(PROTEASE)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 GLY N  98
ALA N  97
GLY N 117
VAL N  59
ILE N  55
 None
 0.89A 2r5pB-3mg6N:
undetectable		 2r5pB-3mg6N:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A51_A_VDYA6178_1
(VITAMIN D
HYDROXYLASE)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		5 / 11 ILE J  59
LEU J  37
ILE J 101
VAL J  97
LEU J  87
 None
 1.24A 3a51A-3mg6J:
undetectable		 3a51A-3mg6J:
18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A51_D_VDYD6178_1
(VITAMIN D
HYDROXYLASE)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		5 / 12 ILE J  59
LEU J  37
ILE J 101
VAL J  97
LEU J  87
 None
 1.23A 3a51D-3mg6J:
undetectable		 3a51D-3mg6J:
18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKY_A_DR7A100_1
(PROTEASE)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 GLY N  98
ALA N  97
GLY N 117
VAL N  59
ILE N  55
 None
 0.99A 3ekyA-3mg6N:
undetectable		 3ekyA-3mg6N:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		4 / 7 LEU J 138
TYR J 124
ILE J   3
ARG J  84
 None
 1.22A 3ik3A-3mg6J:
undetectable		 3ik3A-3mg6J:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		4 / 7 LEU J 138
TYR J 124
ILE J   3
ARG J  84
 None
 1.25A 3ik3B-3mg6J:
undetectable		 3ik3B-3mg6J:
22.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_2_BO221405_1
(PROTEASOME COMPONENT
PRE3
PROTEASOME COMPONENT
PUP1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
SER N  46
GLY N  47
ALA N  49
SER N 168
 None
 0.53A 3mg02-3mg6N:
38.4
3mg0V-3mg6N:
29.3		 3mg02-3mg6N:
100.00
3mg0V-3mg6N:
31.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_H_BO2H1400_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.59A 3mg0H-3mg6N:
29.4
3mg0I-3mg6N:
27.6		 3mg0H-3mg6N:
31.05
3mg0I-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_K_BO2K1402_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		7 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
SER N 129
 None
 0.56A 3mg0K-3mg6N:
29.0
3mg0L-3mg6N:
25.3		 3mg0K-3mg6N:
27.18
3mg0L-3mg6N:
23.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_N_BO2N1404_1
(PROTEASOME COMPONENT
PRE3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  20
ARG N  45
SER N  46
ALA N  49
SER N 169
 None
 1.46A 3mg0N-3mg6N:
38.5		 3mg0N-3mg6N:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_N_BO2N1404_1
(PROTEASOME COMPONENT
PRE3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 11 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
SER N 168
 None
 0.50A 3mg0N-3mg6N:
38.5		 3mg0N-3mg6N:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_V_BO2V1401_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.64A 3mg0V-3mg6N:
29.3
3mg0W-3mg6N:
27.6		 3mg0V-3mg6N:
31.05
3mg0W-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_Y_BO2Y1403_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		7 / 12 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
SER N 129
 None
 0.57A 3mg0Y-3mg6N:
16.6
3mg0Z-3mg6N:
25.0		 3mg0Y-3mg6N:
27.18
3mg0Z-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S3V_A_TOPA193_1
(DIHYDROFOLATE
REDUCTASE)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		4 / 5 ASP N  32
LEU N  34
ILE N 173
PHE N 187
 None
 1.20A 3s3vA-3mg6N:
undetectable		 3s3vA-3mg6N:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.44A 4qvlV-3mg6N:
29.4
4qvlb-3mg6N:
38.7		 4qvlV-3mg6N:
29.49
4qvlb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.41A 4qvlV-3mg6N:
29.4
4qvlb-3mg6N:
38.7		 4qvlV-3mg6N:
29.49
4qvlb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.01A 4qvlK-3mg6N:
29.2
4qvlL-3mg6N:
25.5		 4qvlK-3mg6N:
27.18
4qvlL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.54A 4qvlK-3mg6N:
29.2
4qvlL-3mg6N:
25.5		 4qvlK-3mg6N:
27.18
4qvlL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.43A 4qvlH-3mg6N:
27.5
4qvlN-3mg6N:
38.7		 4qvlH-3mg6N:
29.49
4qvlN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.41A 4qvlH-3mg6N:
27.5
4qvlN-3mg6N:
38.7		 4qvlH-3mg6N:
29.49
4qvlN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.01A 4qvlY-3mg6N:
16.7
4qvlZ-3mg6N:
25.2		 4qvlY-3mg6N:
27.18
4qvlZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVL_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.55A 4qvlY-3mg6N:
16.7
4qvlZ-3mg6N:
25.2		 4qvlY-3mg6N:
27.18
4qvlZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.46A 4qvmV-3mg6N:
29.4
4qvmb-3mg6N:
38.7		 4qvmV-3mg6N:
29.49
4qvmb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qvmV-3mg6N:
29.4
4qvmb-3mg6N:
38.7		 4qvmV-3mg6N:
29.49
4qvmb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.00A 4qvmK-3mg6N:
29.1
4qvmL-3mg6N:
25.4		 4qvmK-3mg6N:
27.18
4qvmL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.57A 4qvmK-3mg6N:
29.1
4qvmL-3mg6N:
25.4		 4qvmK-3mg6N:
27.18
4qvmL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.47A 4qvmH-3mg6N:
27.6
4qvmN-3mg6N:
38.7		 4qvmH-3mg6N:
29.49
4qvmN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qvmH-3mg6N:
27.6
4qvmN-3mg6N:
38.7		 4qvmH-3mg6N:
29.49
4qvmN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.99A 4qvmY-3mg6N:
16.6
4qvmZ-3mg6N:
25.1		 4qvmY-3mg6N:
27.18
4qvmZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVM_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.56A 4qvmY-3mg6N:
16.6
4qvmZ-3mg6N:
25.1		 4qvmY-3mg6N:
27.18
4qvmZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.50A 4qvnV-3mg6N:
29.3
4qvnb-3mg6N:
38.6		 4qvnV-3mg6N:
29.49
4qvnb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.64A 4qvnH-3mg6N:
27.5
4qvnI-3mg6N:
27.5		 4qvnH-3mg6N:
29.49
4qvnI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.59A 4qvnK-3mg6N:
29.2
4qvnL-3mg6N:
25.4		 4qvnK-3mg6N:
27.18
4qvnL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.50A 4qvnH-3mg6N:
27.5
4qvnN-3mg6N:
38.5		 4qvnH-3mg6N:
29.49
4qvnN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.66A 4qvnV-3mg6N:
29.3
4qvnW-3mg6N:
27.6		 4qvnV-3mg6N:
29.49
4qvnW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.59A 4qvnY-3mg6N:
16.7
4qvnZ-3mg6N:
25.2		 4qvnY-3mg6N:
27.18
4qvnZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.49A 4qvpV-3mg6N:
29.3
4qvpb-3mg6N:
38.6		 4qvpV-3mg6N:
29.49
4qvpb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qvpV-3mg6N:
29.3
4qvpb-3mg6N:
38.6		 4qvpV-3mg6N:
29.49
4qvpb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.64A 4qvpH-3mg6N:
27.5
4qvpI-3mg6N:
27.4		 4qvpH-3mg6N:
29.49
4qvpI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.58A 4qvpK-3mg6N:
29.1
4qvpL-3mg6N:
25.1		 4qvpK-3mg6N:
27.18
4qvpL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.49A 4qvpH-3mg6N:
27.5
4qvpN-3mg6N:
38.6		 4qvpH-3mg6N:
29.49
4qvpN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qvpH-3mg6N:
27.5
4qvpN-3mg6N:
38.6		 4qvpH-3mg6N:
29.49
4qvpN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.65A 4qvpV-3mg6N:
29.3
4qvpW-3mg6N:
27.5		 4qvpV-3mg6N:
29.49
4qvpW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.57A 4qvpY-3mg6N:
16.7
4qvpZ-3mg6N:
25.2		 4qvpY-3mg6N:
27.18
4qvpZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.52A 4qvqV-3mg6N:
29.4
4qvqb-3mg6N:
38.5		 4qvqV-3mg6N:
29.49
4qvqb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qvqV-3mg6N:
29.4
4qvqb-3mg6N:
38.5		 4qvqV-3mg6N:
29.49
4qvqb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.63A 4qvqH-3mg6N:
27.5
4qvqI-3mg6N:
27.4		 4qvqH-3mg6N:
29.49
4qvqI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.57A 4qvqK-3mg6N:
29.1
4qvqL-3mg6N:
25.5		 4qvqK-3mg6N:
27.18
4qvqL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.51A 4qvqH-3mg6N:
27.5
4qvqN-3mg6N:
38.6		 4qvqH-3mg6N:
29.49
4qvqN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qvqH-3mg6N:
27.5
4qvqN-3mg6N:
38.6		 4qvqH-3mg6N:
29.49
4qvqN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.62A 4qvqV-3mg6N:
29.4
4qvqW-3mg6N:
27.4		 4qvqV-3mg6N:
29.49
4qvqW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.57A 4qvqY-3mg6N:
16.7
4qvqZ-3mg6N:
25.1		 4qvqY-3mg6N:
27.18
4qvqZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		8 / 10 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
ALA N  49
THR N  52
 None
 0.40A 4qvvV-3mg6N:
29.5
4qvvb-3mg6N:
38.7		 4qvvV-3mg6N:
29.49
4qvvb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.59A 4qvvH-3mg6N:
27.6		 4qvvH-3mg6N:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		4 / 8 THR N   1
THR N  21
LYS N  33
GLY N  47
 None
 0.52A 4qvvK-3mg6N:
29.0
4qvvL-3mg6N:
25.4		 4qvvK-3mg6N:
26.70
4qvvL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		8 / 10 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
ALA N  49
THR N  52
 None
 0.41A 4qvvH-3mg6N:
27.6
4qvvN-3mg6N:
38.7		 4qvvH-3mg6N:
29.49
4qvvN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.59A 4qvvV-3mg6N:
29.5		 4qvvV-3mg6N:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		4 / 8 THR N   1
THR N  21
LYS N  33
GLY N  47
 None
 0.51A 4qvvY-3mg6N:
16.5
4qvvZ-3mg6N:
25.1		 4qvvY-3mg6N:
26.70
4qvvZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.43A 4qvwV-3mg6N:
29.4
4qvwb-3mg6N:
38.8		 4qvwV-3mg6N:
29.49
4qvwb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 4qvwV-3mg6N:
29.4
4qvwb-3mg6N:
38.8		 4qvwV-3mg6N:
29.49
4qvwb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.50A 4qvwK-3mg6N:
29.1
4qvwL-3mg6N:
25.4		 4qvwK-3mg6N:
26.70
4qvwL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.44A 4qvwH-3mg6N:
27.5
4qvwN-3mg6N:
38.8		 4qvwH-3mg6N:
29.49
4qvwN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 4qvwH-3mg6N:
27.5
4qvwN-3mg6N:
38.8		 4qvwH-3mg6N:
29.49
4qvwN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.50A 4qvwY-3mg6N:
16.6
4qvwZ-3mg6N:
25.1		 4qvwY-3mg6N:
26.70
4qvwZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
ALA N  49
THR N  52
 None
 0.33A 4qvyV-3mg6N:
29.4
4qvyb-3mg6N:
38.9		 4qvyV-3mg6N:
29.49
4qvyb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.57A 4qvyH-3mg6N:
28.0		 4qvyH-3mg6N:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.02A 4qvyK-3mg6N:
29.0
4qvyL-3mg6N:
25.3		 4qvyK-3mg6N:
26.70
4qvyL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
ALA N  49
THR N  52
 None
 0.35A 4qvyH-3mg6N:
28.0
4qvyN-3mg6N:
39.1		 4qvyH-3mg6N:
29.49
4qvyN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.57A 4qvyV-3mg6N:
29.4
4qvyW-3mg6N:
27.6		 4qvyV-3mg6N:
29.49
4qvyW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.01A 4qvyY-3mg6N:
16.5
4qvyZ-3mg6N:
25.1		 4qvyY-3mg6N:
26.70
4qvyZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.43A 4qw0V-3mg6N:
29.4
4qw0b-3mg6N:
38.8		 4qw0V-3mg6N:
29.49
4qw0b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 4qw0V-3mg6N:
29.4
4qw0b-3mg6N:
38.8		 4qw0V-3mg6N:
29.49
4qw0b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.60A 4qw0H-3mg6N:
27.5
4qw0I-3mg6N:
27.4		 4qw0H-3mg6N:
29.49
4qw0I-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.44A 4qw0H-3mg6N:
27.5
4qw0N-3mg6N:
38.8		 4qw0H-3mg6N:
29.49
4qw0N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.41A 4qw0H-3mg6N:
27.5
4qw0N-3mg6N:
38.8		 4qw0H-3mg6N:
29.49
4qw0N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.60A 4qw0V-3mg6N:
29.4
4qw0W-3mg6N:
27.4		 4qw0V-3mg6N:
29.49
4qw0W-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.49A 4qw1V-3mg6N:
29.3
4qw1b-3mg6N:
38.6		 4qw1V-3mg6N:
29.49
4qw1b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qw1V-3mg6N:
29.3
4qw1b-3mg6N:
38.6		 4qw1V-3mg6N:
29.49
4qw1b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.61A 4qw1H-3mg6N:
27.5
4qw1I-3mg6N:
27.5		 4qw1H-3mg6N:
29.49
4qw1I-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.98A 4qw1K-3mg6N:
29.1
4qw1L-3mg6N:
25.5		 4qw1K-3mg6N:
26.70
4qw1L-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.58A 4qw1K-3mg6N:
29.1
4qw1L-3mg6N:
25.5		 4qw1K-3mg6N:
26.70
4qw1L-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.49A 4qw1H-3mg6N:
27.5
4qw1N-3mg6N:
38.6		 4qw1H-3mg6N:
29.49
4qw1N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qw1H-3mg6N:
27.5
4qw1N-3mg6N:
38.6		 4qw1H-3mg6N:
29.49
4qw1N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.61A 4qw1V-3mg6N:
29.3
4qw1W-3mg6N:
27.5		 4qw1V-3mg6N:
29.49
4qw1W-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.98A 4qw1Y-3mg6N:
16.6
4qw1Z-3mg6N:
25.2		 4qw1Y-3mg6N:
26.70
4qw1Z-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.57A 4qw1Y-3mg6N:
16.6
4qw1Z-3mg6N:
25.2		 4qw1Y-3mg6N:
26.70
4qw1Z-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.44A 4qw3V-3mg6N:
29.4
4qw3b-3mg6N:
38.5		 4qw3V-3mg6N:
29.49
4qw3b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qw3V-3mg6N:
29.4
4qw3b-3mg6N:
38.5		 4qw3V-3mg6N:
29.49
4qw3b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.00A 4qw3K-3mg6N:
29.0
4qw3L-3mg6N:
25.4		 4qw3K-3mg6N:
27.18
4qw3L-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.55A 4qw3K-3mg6N:
29.0
4qw3L-3mg6N:
25.4		 4qw3K-3mg6N:
27.18
4qw3L-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.47A 4qw3H-3mg6N:
27.5
4qw3N-3mg6N:
38.5		 4qw3H-3mg6N:
29.49
4qw3N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qw3H-3mg6N:
27.5
4qw3N-3mg6N:
38.5		 4qw3H-3mg6N:
29.49
4qw3N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.99A 4qw3Y-3mg6N:
16.6
4qw3Z-3mg6N:
25.0		 4qw3Y-3mg6N:
27.18
4qw3Z-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW3_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.55A 4qw3Y-3mg6N:
16.6
4qw3Z-3mg6N:
25.0		 4qw3Y-3mg6N:
27.18
4qw3Z-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.54A 4qwuV-3mg6N:
29.3
4qwub-3mg6N:
38.2		 4qwuV-3mg6N:
29.49
4qwub-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qwuV-3mg6N:
29.3
4qwub-3mg6N:
38.2		 4qwuV-3mg6N:
29.49
4qwub-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.67A 4qwuH-3mg6N:
27.3
4qwuI-3mg6N:
27.5		 4qwuH-3mg6N:
29.49
4qwuI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.54A 4qwuK-3mg6N:
28.0
4qwuL-3mg6N:
25.2		 4qwuK-3mg6N:
27.18
4qwuL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.55A 4qwuH-3mg6N:
27.3
4qwuN-3mg6N:
38.3		 4qwuH-3mg6N:
29.49
4qwuN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 4qwuH-3mg6N:
27.3
4qwuN-3mg6N:
38.3		 4qwuH-3mg6N:
29.49
4qwuN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.66A 4qwuV-3mg6N:
29.3
4qwuW-3mg6N:
27.6		 4qwuV-3mg6N:
29.49
4qwuW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 0.59A 4qwuY-3mg6N:
16.4
4qwuZ-3mg6N:
25.2		 4qwuY-3mg6N:
27.18
4qwuZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.48A 5bxnV-3mg6N:
29.6
5bxnb-3mg6N:
38.6		 5bxnV-3mg6N:
29.49
5bxnb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 5bxnV-3mg6N:
29.6
5bxnb-3mg6N:
38.6		 5bxnV-3mg6N:
29.49
5bxnb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.57A 5bxnH-3mg6N:
29.5
5bxnI-3mg6N:
27.6		 5bxnH-3mg6N:
29.49
5bxnI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.01A 5bxnK-3mg6N:
29.1
5bxnL-3mg6N:
25.1		 5bxnK-3mg6N:
27.18
5bxnL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.58A 5bxnK-3mg6N:
29.1
5bxnL-3mg6N:
25.1		 5bxnK-3mg6N:
27.18
5bxnL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.47A 5bxnH-3mg6N:
29.5
5bxnN-3mg6N:
38.6		 5bxnH-3mg6N:
29.49
5bxnN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 5bxnH-3mg6N:
29.5
5bxnN-3mg6N:
38.6		 5bxnH-3mg6N:
29.49
5bxnN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.54A 5bxnV-3mg6N:
29.6
5bxnW-3mg6N:
27.6		 5bxnV-3mg6N:
29.49
5bxnW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
 None
 1.01A 5bxnY-3mg6N:
16.6
5bxnZ-3mg6N:
25.1		 5bxnY-3mg6N:
27.18
5bxnZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.58A 5bxnY-3mg6N:
16.6
5bxnZ-3mg6N:
25.1		 5bxnY-3mg6N:
27.18
5bxnZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		8 / 9 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
ALA N  49
THR N  52
 None
 0.43A 5cz7V-3mg6N:
29.4
5cz7b-3mg6N:
38.7		 5cz7V-3mg6N:
29.49
5cz7b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.48A 5cz7H-3mg6N:
27.5
5cz7N-3mg6N:
38.7		 5cz7H-3mg6N:
29.49
5cz7N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.43A 5cz7H-3mg6N:
27.5
5cz7N-3mg6N:
38.7		 5cz7H-3mg6N:
29.49
5cz7N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.60A 5cz7V-3mg6N:
29.4
5cz7W-3mg6N:
27.5		 5cz7V-3mg6N:
29.49
5cz7W-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.43A 5d0xV-3mg6N:
29.5
5d0xb-3mg6N:
38.7		 5d0xV-3mg6N:
29.49
5d0xb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 5d0xV-3mg6N:
29.5
5d0xb-3mg6N:
38.7		 5d0xV-3mg6N:
29.49
5d0xb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
THR N  21
LYS N  33
ALA N  49
THR N  52
 None
 0.57A 5d0xH-3mg6N:
27.9
5d0xI-3mg6N:
27.4		 5d0xH-3mg6N:
29.49
5d0xI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 9 THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.58A 5d0xK-3mg6N:
29.1
5d0xL-3mg6N:
25.4		 5d0xK-3mg6N:
26.70
5d0xL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.44A 5d0xH-3mg6N:
27.9
5d0xN-3mg6N:
38.7		 5d0xH-3mg6N:
29.49
5d0xN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 5d0xH-3mg6N:
27.9
5d0xN-3mg6N:
38.7		 5d0xH-3mg6N:
29.49
5d0xN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.58A 5d0xV-3mg6N:
29.5		 5d0xV-3mg6N:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 9 THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.59A 5d0xY-3mg6N:
16.7
5d0xZ-3mg6N:
25.1		 5d0xY-3mg6N:
26.70
5d0xZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I6X_A_8PRA705_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		5 / 10 ALA J  56
ILE J  59
GLY J 102
SER J  38
VAL J  99
 None
 1.20A 5i6xA-3mg6J:
undetectable		 5i6xA-3mg6J:
17.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
ALA N  49
THR N  52
 None
 0.41A 5l5fV-3mg6N:
29.4
5l5fb-3mg6N:
38.8		 5l5fV-3mg6N:
29.49
5l5fb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.64A 5l5fH-3mg6N:
27.5
5l5fI-3mg6N:
27.6		 5l5fH-3mg6N:
29.49
5l5fI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
ALA N  49
THR N  52
 None
 0.43A 5l5fH-3mg6N:
27.5
5l5fN-3mg6N:
38.8		 5l5fH-3mg6N:
29.49
5l5fN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.63A 5l5fV-3mg6N:
29.4
5l5fW-3mg6N:
27.6		 5l5fV-3mg6N:
29.49
5l5fW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5Z_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
THR N  52
 None
 0.48A 5l5zV-3mg6N:
29.4
5l5zb-3mg6N:
38.7		 5l5zV-3mg6N:
29.49
5l5zb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5Z_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.64A 5l5zH-3mg6N:
27.5
5l5zI-3mg6N:
27.7		 5l5zH-3mg6N:
29.49
5l5zI-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5Z_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA
TYPE-5,PROTEASOME
SUBUNIT BETA TYPE-5
PROTEASOME SUBUNIT
BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.71A 5l5zK-3mg6N:
29.2
5l5zL-3mg6N:
25.0		 5l5zK-3mg6N:
28.37
5l5zL-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5Z_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
THR N  52
 None
 0.47A 5l5zH-3mg6N:
27.5
5l5zN-3mg6N:
38.7		 5l5zH-3mg6N:
29.49
5l5zN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5Z_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.65A 5l5zV-3mg6N:
29.4
5l5zW-3mg6N:
27.6		 5l5zV-3mg6N:
29.49
5l5zW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5Z_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA
TYPE-5,PROTEASOME
SUBUNIT BETA TYPE-5
PROTEASOME SUBUNIT
BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 9 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.71A 5l5zY-3mg6N:
29.2
5l5zZ-3mg6N:
25.0		 5l5zY-3mg6N:
28.37
5l5zZ-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.48A 5l66V-3mg6N:
29.4
5l66b-3mg6N:
38.7		 5l66V-3mg6N:
29.49
5l66b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 5l66V-3mg6N:
29.4
5l66b-3mg6N:
38.7		 5l66V-3mg6N:
29.49
5l66b-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA
TYPE-8,PROTEASOME
SUBUNIT BETA TYPE-5
PROTEASOME SUBUNIT
BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.58A 5l66K-3mg6N:
14.0
5l66L-3mg6N:
25.3		 5l66K-3mg6N:
28.50
5l66L-3mg6N:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		9 / 11 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.49A 5l66H-3mg6N:
27.5
5l66N-3mg6N:
38.7		 5l66H-3mg6N:
29.49
5l66N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N  21
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 1.42A 5l66H-3mg6N:
27.5
5l66N-3mg6N:
38.7		 5l66H-3mg6N:
29.49
5l66N-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA
TYPE-8,PROTEASOME
SUBUNIT BETA TYPE-5
PROTEASOME SUBUNIT
BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.59A 5l66Y-3mg6N:
29.2
5l66Z-3mg6N:
25.0		 5l66Y-3mg6N:
28.50
5l66Z-3mg6N:
23.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_B_BO2B305_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
SER N 129
 None
 1.45A 5lf3b-3mg6N:
34.2		 5lf3b-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_B_BO2B305_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
ARG N  45
GLY N  98
THR N  52
SER N 131
 None
 1.09A 5lf3b-3mg6N:
34.2		 5lf3b-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_B_BO2B305_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 12 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
THR N  52
SER N 168
 None
 0.57A 5lf3b-3mg6N:
34.2		 5lf3b-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_B_BO2B305_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 THR N  20
ARG N  45
SER N  46
ALA N  49
THR N  52
SER N 169
 None
 1.41A 5lf3b-3mg6N:
34.2		 5lf3b-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_H_BO2H306_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 10 THR N   1
THR N  21
GLY N  47
ALA N  49
THR N  52
 None
 0.51A 5lf3H-3mg6N:
30.6
5lf3I-3mg6N:
27.8		 5lf3H-3mg6N:
30.57
5lf3I-3mg6N:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LF3_K_BO2K305_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.63A 5lf3K-3mg6N:
29.8
5lf3L-3mg6N:
26.8		 5lf3K-3mg6N:
27.23
5lf3L-3mg6N:
23.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_N_BO2N304_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
SER N 129
 None
 1.45A 5lf3N-3mg6N:
34.3		 5lf3N-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_N_BO2N304_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 12 THR N   1
ARG N  45
GLY N  98
THR N  52
SER N 131
 None
 1.09A 5lf3N-3mg6N:
34.3		 5lf3N-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_N_BO2N304_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 12 THR N   1
THR N  20
THR N  21
THR N  22
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
THR N  52
SER N 168
 None
 0.55A 5lf3N-3mg6N:
34.3		 5lf3N-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_N_BO2N304_1
(PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 THR N  20
ARG N  45
SER N  46
ALA N  49
THR N  52
SER N 169
 None
 1.40A 5lf3N-3mg6N:
34.3		 5lf3N-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_V_BO2V303_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 10 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.60A 5lf3V-3mg6N:
30.7
5lf3W-3mg6N:
27.8		 5lf3V-3mg6N:
30.57
5lf3W-3mg6N:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LF3_Y_BO2Y305_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-1)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.63A 5lf3Y-3mg6N:
29.8
5lf3Z-3mg6N:
26.8		 5lf3Y-3mg6N:
27.23
5lf3Z-3mg6N:
23.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_B_6V8B304_0
(PROTEASOME SUBUNIT
BETA TYPE-6
PROTEASOME SUBUNIT
BETA TYPE-7)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
THR N  52
 None
 0.56A 5lf7V-3mg6N:
30.7
5lf7b-3mg6N:
34.2		 5lf7V-3mg6N:
30.57
5lf7b-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_H_6V8H305_0
(PROTEASOME SUBUNIT
BETA TYPE-3
PROTEASOME SUBUNIT
BETA TYPE-7)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
GLY N  47
ALA N  49
THR N  52
 None
 0.49A 5lf7H-3mg6N:
30.7
5lf7I-3mg6N:
27.7		 5lf7H-3mg6N:
30.57
5lf7I-3mg6N:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LF7_K_6V8K305_0
(PROTEASOME SUBUNIT
BETA TYPE-1
PROTEASOME SUBUNIT
BETA TYPE-5)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.64A 5lf7K-3mg6N:
29.7
5lf7L-3mg6N:
26.8		 5lf7K-3mg6N:
27.23
5lf7L-3mg6N:
23.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_N_6V8N305_0
(PROTEASOME SUBUNIT
BETA TYPE-6
PROTEASOME SUBUNIT
BETA TYPE-7)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		11 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
SER N  46
GLY N  47
ALA N  49
THR N  52
 None
 0.57A 5lf7H-3mg6N:
30.7
5lf7N-3mg6N:
34.3		 5lf7H-3mg6N:
30.57
5lf7N-3mg6N:
53.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_V_6V8V303_0
(PROTEASOME SUBUNIT
BETA TYPE-3
PROTEASOME SUBUNIT
BETA TYPE-7)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
GLY N  47
ALA N  49
THR N  52
 None
 0.45A 5lf7V-3mg6N:
30.7
5lf7W-3mg6N:
27.8		 5lf7V-3mg6N:
30.57
5lf7W-3mg6N:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LF7_Y_6V8Y306_0
(PROTEASOME SUBUNIT
BETA TYPE-1
PROTEASOME SUBUNIT
BETA TYPE-5)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		5 / 11 THR N   1
THR N  21
LYS N  33
GLY N  47
ALA N  49
 None
 0.63A 5lf7Y-3mg6N:
29.8
5lf7Z-3mg6N:
26.8		 5lf7Y-3mg6N:
27.23
5lf7Z-3mg6N:
23.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EF6_A_BEZA401_0
(AMINOGLYCOSIDE
PHOSPHOTRANSFERASE)		 3mg6 PROTEASOME COMPONENT
C11
(Saccharomyces
cerevisiae) 		5 / 9 LEU J  37
SER J  38
THR J  41
ILE J 101
VAL J  83
 None
 1.24A 6ef6A-3mg6J:
undetectable		 6ef6A-3mg6J:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_B_BO2B201_0
(PROTEASOME SUBUNIT
BETA TYPE-1
PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.50A 6hwdV-3mg6N:
29.4
6hwdb-3mg6N:
38.6		 6hwdV-3mg6N:
20.92
6hwdb-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_H_BO2H301_0
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 12 THR N   1
ALA N  27
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.60A 6hwdH-3mg6N:
27.5
6hwdI-3mg6N:
27.5		 6hwdH-3mg6N:
20.92
6hwdI-3mg6N:
17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_K_BO2K301_0
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.61A 6hwdK-3mg6N:
28.9
6hwdL-3mg6N:
25.4		 6hwdK-3mg6N:
20.33
6hwdL-3mg6N:
15.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_N_BO2N201_0
(PROTEASOME SUBUNIT
BETA TYPE-1
PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		10 / 12 THR N   1
THR N  20
THR N  21
THR N  22
ALA N  27
LYS N  33
ARG N  45
GLY N  47
ALA N  49
THR N  52
 None
 0.50A 6hwdH-3mg6N:
27.5
6hwdN-3mg6N:
38.6		 6hwdH-3mg6N:
20.92
6hwdN-3mg6N:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_V_BO2V301_0
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
ALA N  27
LYS N  33
GLY N  47
ALA N  49
THR N  52
 None
 0.59A 6hwdV-3mg6N:
29.4		 6hwdV-3mg6N:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_Y_BO2Y301_0
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3mg6 PROTEASOME COMPONENT
PRE3
(Saccharomyces
cerevisiae) 		6 / 11 THR N   1
THR N  21
ALA N  27
LYS N  33
GLY N  47
ALA N  49
 None
 0.61A 6hwdY-3mg6N:
16.8
6hwdZ-3mg6N:
25.2		 6hwdY-3mg6N:
20.33
6hwdZ-3mg6N:
15.31